Literature DB >> 1923965

Suppressive antibiotic therapy in chronic prosthetic joint infections.

D T Tsukayama1, B Wicklund, R B Gustilo.   

Abstract

Thirteen patients with chronic total joint infections (eight knees, five hips) were treated with suppressive antibiotic therapy and retention of the prosthesis following surgical debridement and 4 to 6 weeks of intravenous antibiotic therapy. These patients faced poor functional outcome after prosthesis removal. After a mean follow up of 37.6 months (range: 24 to 55), only three patients have retained their prostheses. Ten patients required prosthesis removal for recurrent infection a mean of 21.6 months (range: 6 to 48) after starting suppressive therapy. In addition, 38% of patients experienced adverse effects which led to changes in the antibiotic regimen. Suppressive antibiotic therapy in the treatment of chronic prosthesis infections has limited clinical efficacy and is associated with a substantial risk of adverse effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923965     DOI: 10.3928/0147-7447-19910801-07

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  17 in total

1.  Treatment Options for Orthopedic Device-related Infections.

Authors:  Edna Toubes; John Segreti
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

2.  Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention.

Authors:  O C El Helou; E F Berbari; B D Lahr; J E Eckel-Passow; R R Razonable; I G Sia; A Virk; R C Walker; J M Steckelberg; W R Wilson; A D Hanssen; D R Osmon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-27       Impact factor: 3.267

3.  Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection.

Authors:  T Ferry; I Uçkay; P Vaudaux; P François; J Schrenzel; S Harbarth; F Laurent; L Bernard; F Vandenesch; J Etienne; P Hoffmeyer; D Lew
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-28       Impact factor: 3.267

Review 4.  Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection.

Authors:  Ryan S Charette; Christopher M Melnic
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

Review 5.  [Periprosthetic infections in patients with rheumatism : A challenge].

Authors:  J Fussi; C Perka; L Renner
Journal:  Z Rheumatol       Date:  2016-12       Impact factor: 1.372

6.  Prolonged suppressive antibiotic therapy is successful in the management of prosthetic joint infection.

Authors:  N A Sandiford; J R Hutt; D O Kendoff; P A Mitchell; M Citak; L Granger
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-10-01

7.  Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.

Authors:  V Prendki; T Ferry; P Sergent; E Oziol; E Forestier; T Fraisse; S Tounes; S Ansart; J Gaillat; S Bayle; O Ruyer; F Borlot; G Le Falher; B Simorre; F-A Dauchy; S Greffe; T Bauer; E N Bell; B Martha; M Martinot; M Froidure; M Buisson; A Waldner; X Lemaire; A Bosseray; M Maillet; V Charvet; A Barrelet; B Wyplosz; M Noaillon; E Denes; E Beretti; M Berlioz-Thibal; V Meyssonnier; E Fourniols; L Tliba; A Eden; M Jean; C Arvieux; K Guignery-Kadri; C Ronde-Oustau; Y Hansmann; A Belkacem; F Bouchand; G Gavazzi; F Herrmann; J Stirnemann; A Dinh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-04       Impact factor: 3.267

Review 8.  Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

9.  Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis.

Authors:  Andrej Trampuz; Werner Zimmerli
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

10.  Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patients.

Authors:  M Pradier; O Robineau; A Boucher; M Titecat; N Blondiaux; M Valette; C Loïez; E Beltrand; S Nguyen; H Dézeque; H Migaud; Eric Senneville
Journal:  Infection       Date:  2017-10-20       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.